Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

PMV Pharmaceuticals, Inc. Director's Dealing 2022

Jan 10, 2022

34350_dirs_2022-01-10_d415ba8f-c930-4017-8d94-05e63e000518.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2022-01-05

Reporting Person: FLOWERS KIRSTEN (Director)

More from PMV Pharmaceuticals, Inc.

Interim / Quarterly Report 2026
May 12
Regulatory Filings 2026
May 12
Annual Report 2026
Apr 22
Proxy Solicitation & Information Statement 2026
Apr 22
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 9
Interim / Quarterly Report 2025
Nov 12
Regulatory Filings 2025
Nov 12
Major Shareholding Notification 2025
Nov 12
Director's Dealing 2025
Oct 29
View all filings →